During the past decade, the second affiliated hospital of Dalian medical university conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 5 clinical trials were completed, i.e. on average, 15.6% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 4 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "the second affiliated hospital of Dalian medical university" #1 sponsor was "Harbin Medical University" with 4 trials, followed by "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "DK Medical Technology (Suzhou) Co., Ltd." with 2 trials sponsored and "Liaoning University of Traditional Chinese Medicine" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "the second affiliated hospital of Dalian medical university" #1 collaborator was "Beijing University of Chinese Medicine" with 2 trials as a collaborator, "Core Medical (Beijing) Co., Ltd." with 2 trials as a collaborator, "Sponsor GmbH" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "Beijing Anzhen Hospital" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "the second affiliated hospital of Dalian medical university" are "Acute Myocardial Infarction" (3 trials), "Breast Cancer" (2 trials), "Carcinoma, Hepatocellular" (2 trials), "Heart Failure" (2 trials) and "Pneumonia" (2 trials). Many other conditions were trialed in "the second affiliated hospital of Dalian medical university" in a lesser frequency.

Most popular intervention types in "the second affiliated hospital of Dalian medical university" are "Drug" (23 trials), "Device" (5 trials), "Other" (3 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Fulvestrant" (2 trials), "JS005" (2 trials), "LY2963016" (2 trials) and "Lantus®" (2 trials). Other intervention names were less common.

The vast majority of trials in "the second affiliated hospital of Dalian medical university" are 33 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "the second affiliated hospital of Dalian medical university". 2 are not yet recruiting, 9 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in the second affiliated hospital of Dalian medical university, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in the second affiliated hospital of Dalian medical university, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 9 trials that are defined as “Not Applicable".